BLNK as an important prognostic indicator for survival in pediatric classic hodgkin lymphoma patients: a single-center retrospective study

Abstract Classic Hodgkin lymphoma (cHL) is a malignant tumor in children. At present, some patients cannot be cured with first-line treatment, and many cured patients die prematurely because of the late toxic effects of treatment. In addition, effective early survival prediction biomarkers are lacki...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yiwei Yan, Yuanyuan Hou, Xiuli Zhu, Jian Chen, Wenting Zhang, Yuqiao Diao, Xiaofei Lu, Lian Jiang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer 2025-10-01
coleção:	Annals of Hematology
Assuntos:	BLNK Classic hodgkin lymphoma Progression free survival Overall survival Nomogram
Acesso em linha:	https://doi.org/10.1007/s00277-025-06697-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!